caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518929561

Jayne Cole

Nurse PractitionerMerrillville, INI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jayne Cole's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 18 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Murugavel Muthusamy
Hematology-Oncology · Fort Wayne, IN
1991,451
Olusola Ogundipe
Hematology-Oncology · Valparaiso, IN
115619
George Sloan
Hematology-Oncology · Valparaiso, IN
951,529
PORTER HOSPITAL LLC77292
Brendan Banyon
Diagnostic Radiology · Grand Rapids, MI
2636
INDIANA UNIVERSITY HEALTH LA PORTE HOSPITAL INC2560
Omar Barakat
Diagnostic Radiology · Valparaiso, IN
2052
Esther Lee
Diagnostic Radiology · Valparaiso, IN
1929
Jeffrey Huth
Diagnostic Radiology · Valparaiso, IN
1830
Richard Dobben
Diagnostic Radiology · Michigan City, IN
1730
Vivek Mishra
Diagnostic Radiology · Laporte, IN
1628
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1642
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
49
Beneficiaries
—
Total drug cost
$771
Distinct drugs
3
Brand share
0.0%
Top prescribed drugs
Anastrozole18 claims
Hydroxyurea17 claims
Levothyroxine Sodium14 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$545
Payment records
8
By payment type
Long term medical supply or device loan$500
Food and Beverage$45